Zevra Therapeutics, Inc.
ZVRA
$12.23
-$0.45-3.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 221.57M | 200.62M | 191.01M | 199.51M | 202.61M |
| Total Receivables | 22.49M | 22.10M | 23.26M | 16.84M | 18.27M |
| Inventory | 2.45M | 2.31M | 1.74M | 1.37M | 1.11M |
| Prepaid Expenses | 4.79M | 4.94M | 7.00M | 7.40M | 4.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 251.30M | 229.97M | 223.01M | 225.12M | 226.34M |
|
|
|||||
| Total Current Assets | 251.30M | 229.97M | 223.01M | 225.12M | 226.34M |
| Net Property, Plant & Equipment | 2.31M | 1.52M | 1.70M | 1.83M | 2.10M |
| Long-term Investments | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
| Goodwill | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
| Total Other Intangibles | 5.79M | 6.11M | 6.42M | 6.74M | 7.05M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.00K | 143.00K | 1.02M | 873.00K | 1.00M |
| Total Assets | 302.71M | 278.58M | 284.73M | 270.12M | 256.28M |
|
|
|||||
| Total Accounts Payable | 13.96M | 11.69M | 2.48M | 11.07M | 15.84M |
| Total Accrued Expenses | 11.78M | 13.17M | 21.31M | 5.61M | 5.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 626.00K | 406.00K | 419.00K | 441.00K | 525.00K |
| Total Finance Division Other Current Liabilities | 22.27M | 21.76M | 15.07M | 8.99M | 6.87M |
| Total Other Current Liabilities | 22.27M | 21.76M | 15.07M | 8.99M | 6.87M |
| Total Current Liabilities | 48.63M | 47.03M | 39.28M | 26.11M | 28.83M |
|
|
|||||
| Total Current Liabilities | 48.63M | 47.03M | 39.28M | 26.11M | 28.83M |
| Long-Term Debt | -- | -- | 61.93M | 61.31M | 60.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 870.00K | 741.00K | 859.00K | 966.00K | 1.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.56M | 25.01M | 28.01M | 48.56M | 48.46M |
| Total Liabilities | 85.06M | 72.78M | 130.07M | 136.95M | 139.05M |
|
|
|||||
| Common Stock & APIC | 606.27M | 602.75M | 588.46M | 580.79M | 564.32M |
| Retained Earnings | -375.42M | -384.17M | -422.06M | -434.23M | -433.68M |
| Treasury Stock & Other | -13.20M | -12.78M | -11.75M | -13.40M | -13.41M |
| Total Common Equity | 217.65M | 205.80M | 154.66M | 133.17M | 117.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 217.65M | 205.80M | 154.66M | 133.17M | 117.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 217.65M | 205.80M | 154.66M | 133.17M | 117.23M |
|
|
|||||